Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Aarsland, Dag
Marsh, Laura
and
Schrag, Anette
2009.
Neuropsychiatric symptoms in Parkinson's disease.
Movement Disorders,
Vol. 24,
Issue. 15,
p.
2175.
Asadabadi, Ebrahim Barzegari
Abdolmaleki, Parviz
Barkooie, Seyyed Mohsen Hosseini
Jahandideh, Samad
and
Rezaei, Mohammad Ali
2009.
A combinatorial feature selection approach to describe the QSAR of dual site inhibitors of acetylcholinesterase.
Computers in Biology and Medicine,
Vol. 39,
Issue. 12,
p.
1089.
Thomsen, Teri R.
and
Rodnitzky, Robert L.
2010.
Juvenile Parkinsonism.
CNS Drugs,
Vol. 24,
Issue. 6,
p.
467.
Fénelon, G.
2010.
Encyclopedia of Movement Disorders.
p.
3.
Zahodne, L.B.
and
Fernandez, H.H.
2010.
Encyclopedia of Movement Disorders.
p.
499.
Kapfhammer, H.-P.
2011.
Psychiatrie, Psychosomatik, Psychotherapie.
p.
2511.
Friedman, Joseph H.
2011.
Parkinson's Disease.
p.
170.
Xu, J.
Gong, D.D.
Man, C.F.
and
Fan, Y.
2014.
Parkinson's disease and risk of mortality: meta-analysis and systematic review.
Acta Neurologica Scandinavica,
Vol. 129,
Issue. 2,
p.
71.
Moustafa, Ahmed A.
Krishna, Rakhee
Frank, Michael J.
Eissa, Abeer M.
and
Hewedi, Doaa H.
2014.
Cognitive correlates of psychosis in patients with Parkinson's disease.
Cognitive Neuropsychiatry,
Vol. 19,
Issue. 5,
p.
381.
Kapfhammer, H.-P.
2015.
Psychiatrie, Psychosomatik, Psychotherapie.
p.
1.
Ojo, Oluwadamilola O.
and
Fernandez, Hubert H.
2016.
Current Understanding of Psychosis in Parkinson’s Disease.
Current Psychiatry Reports,
Vol. 18,
Issue. 10,
Lenka, Abhishek
Arumugham, Shyam Sundar
Christopher, Rita
and
Pal, Pramod Kumar
2016.
Genetic substrates of psychosis in patients with Parkinson's disease: A critical review.
Journal of the Neurological Sciences,
Vol. 364,
Issue. ,
p.
33.
Bozymski, Kevin M.
Lowe, Denise K.
Pasternak, Kiersten M.
Gatesman, Travis L.
and
Crouse, Ericka L.
2017.
Pimavanserin: A Novel Antipsychotic for Parkinson’s Disease Psychosis.
Annals of Pharmacotherapy,
Vol. 51,
Issue. 6,
p.
479.
Hermanowicz, Neal
Alva, Gustavo
Pagan, Fernando
Espay, Alberto J.
Patel, Amita
Madrid, Katya Cruz
Kremens, Daniel
Kenney, Jim
Arquette, Sheila
Tereso, Gary
Lopes, Maria
and
Farnum, Carolyn
2017.
The Emerging Role of Pimavanserin in the Management of Parkinson’s Disease Psychosis.
Journal of Managed Care & Specialty Pharmacy,
Vol. 23,
Issue. 6-b Suppl,
p.
S2.
Lenka, Abhishek
George, Lija
Arumugham, Shyam Sundar
Hegde, Shantala
Reddy, Venkateswara
Kamble, Nitish
Yadav, Ravi
and
Pal, Pramod Kumar
2017.
Predictors of onset of psychosis in patients with Parkinson's disease: Who gets it early?.
Parkinsonism & Related Disorders,
Vol. 44,
Issue. ,
p.
91.
Kapfhammer, Hans-Peter
2017.
Psychiatrie, Psychosomatik, Psychotherapie.
p.
2693.
Lenka, Abhishek
Hegde, Shantala
Arumugham, Shyam Sundar
and
Pal, Pramod Kumar
2017.
Pattern of cognitive impairment in patients with Parkinson's disease and psychosis: A critical review.
Parkinsonism & Related Disorders,
Vol. 37,
Issue. ,
p.
11.
Thota, Naveen
Lenka, Abhishek
George, Lija
Hegde, Shantala
Arumugham, Shyam Sundar
Prasad, Shweta
Stezin, Albert
Kamble, Nitish
Yadav, Ravi
and
Pal, Pramod Kumar
2017.
Impaired frontal lobe functions in patients with Parkinson’s disease and psychosis.
Asian Journal of Psychiatry,
Vol. 30,
Issue. ,
p.
192.
Lenka, Abhishek
Herath, Priyantha
Christopher, Rita
and
Pal, Pramod Kumar
2017.
Psychosis in Parkinson's disease: From the soft signs to the hard science.
Journal of the Neurological Sciences,
Vol. 379,
Issue. ,
p.
169.
Li, Lin
Liu, Ming-Su
Li, Guang-Qin
Tang, Jie
Liao, Yan
Zheng, Yang
Guo, Tong-Li
Kang, Xin
and
Yuan, Mao-Ting
2017.
Relationship between Apolipoprotein Superfamily and Parkinson's Disease.
Chinese Medical Journal,
Vol. 130,
Issue. 21,
p.
2616.